Betta Pharmaceuticals Co Ltd (300558) — Long-term Investment Intensity

Latest as of September 2019: 1.8%

Betta Pharmaceuticals Co Ltd (300558) has a Long-term Investment Intensity of 1.8% as of September 2019. Long-term investments of CN¥70.32 Million represent 1.8% of total assets of CN¥4.00 Billion. A higher ratio indicates a company with significant capital committed to long-duration strategic positions. Check financial resilience of Betta Pharmaceuticals Co Ltd to evaluate the company's liquid asset resilience ratio.

LT Investment Intensity

1.8%
LT Investments / Total Assets

Long-term Investments

CN¥70.32 Million
CNY

Total Assets

CN¥4.00 Billion
CNY

Country

China
SHE

Betta Pharmaceuticals Co Ltd Long-term Investment Intensity (2015–2018)

This chart shows how Betta Pharmaceuticals Co Ltd's Long-term Investment Intensity has evolved across 4 annual periods from 2015 to 2018. As of September 2019, the intensity stands at 1.8%, reflecting long-term investments of CN¥70.32 Million against total assets of CN¥4.00 Billion CNY. For the complete balance sheet picture, see Betta Pharmaceuticals Co Ltd asset portfolio.

Annual Long-term Investment Intensity for Betta Pharmaceuticals Co Ltd (2015–2018)

The table below presents the year-by-year Long-term Investment Intensity for Betta Pharmaceuticals Co Ltd from 2015 to 2018, covering 4 annual filings. Each row shows total assets, long-term investments, the intensity percentage, and the change in percentage points compared to the prior year. Read Betta Pharmaceuticals Co Ltd total liabilities for a breakdown of total debt and financial obligations.

Year LT Investment Intensity LT Investments (CNY) Total Assets Change (pp)
2018 2.4% CN¥85.85 Million CN¥3.51 Billion ▼ -3.0 pp
2017 5.5% CN¥152.26 Million CN¥2.77 Billion ▼ -1.1 pp
2016 6.6% CN¥143.17 Million CN¥2.17 Billion ▼ -4.8 pp
2015 11.4% CN¥130.31 Million CN¥1.15 Billion
pp = percentage points